Skip to main content

Lansley's CCGs will cost £1.334bn a year to run.

Yesterday, the government published the list of the 212 Clinical Commissioning Groups that are to be established throughout England. Some will serve populations as low as 67,000 while other super-CCGs will cater for nearly 1 million patients. (see the full list here).


For the first time the government have published an expectation of the costs in running their new CCG structure.  A closer examination of the government's data shows that annual costs just to run the CCGs will amount to £1.334 billion a year. Over the course of a parliamentary term this is a combined running cost of £6.67bn. The chairs of the CCGs will for 2 days work a week be given £40,000 each. Two other part time staff will earn smaller sums of £25k. In terms of the calculation of the running costs, there also appears to be some disparity. By dividing total running costs by the number of patients a CCG expects to serve, we can say that some CCGs such as North Somerset CCG will cost £26 per patient to run, while other CCGs such as Brent or Lambeth will be allocated just £21 per patient. Quite why some CCGs are being allocated 25% more funds to run their CCG is not clear. 

I see no reason why we cannot call these CCGs quangos myself, which after Cameron's promise to have a bonfire of quangos one must ask if the creation of 212 CCGs was counter-productive to that goal.


The government's lack of direction in guiding CCGs on appropriate sizes and mergers has undoubtedly part caused this disparity. One of the chief consequences of it is that inequality & the post code lottery has been exacerbated because wealthier areas have joined together to form larger CCGs and excluded neighbouring GP practices from poorer areas from merging with them. Pulse have reported that the areas most likely to suffer as a result are the West Midlands, and in particular Birmingham, as well as the East of England (see more of Pulse's research here).

Comments

Popular posts from this blog

clip on magnetic sunglasses visit here

Save with prescription glasses and sunglasses. Prescription eyeglasses with magnetic clip on sunglasses. A wide selection of colors and styles for every budget! -GlassesPoint. Prescription eyeglasses with magnetic clip on sunglasses. A wide selection of colors and styles for every budget! Free magnetic clip on with every pair of glasses.  The operator should contact lens Plano glasses a few days of Sun and Rx on the other person. Many people choose single vision lenses, designed for a specific use, such as prescription sunglasses. Clip-ons magnetic magnetic clip ons often come with their prescription glasses frames. Prescription glasses Goggles4u dollars from 29.99 with free shipping. Takumi neodium magnet glass features recipes that are light, strong and in. The combination of some normal prescription glasses and a pair of polarized glasses that glare-resistant to outdoor activities. clip on magnetic sunglasses visit here

The Tragedy of Underfunded Mental Health Care

Today’s Managing Health Care Costs Indicator is   19,900 The NY Times  on Friday had a deeply disturbing article on a murder that stunned the mental health community here in Massachusetts.    A long-term schizophrenic man, off his medicine and spiraling into incoherence, killed a young female counselor who was the sole worker at a group home in a Boston suburb.   His mother, who works at a Boston teaching hospital, was frantic with worry as her adult son, who had been arrested for assault multiple times, was becoming more psychotic.    It was hard for her to get anyone’s attention. The counselor was the first in her family to get a college degree, and had just decided to go to nursing school.    Now she’s dead – and her family had trouble scraping together the resources for a burial.   The schizophrenic will be imprisoned for the rest of his life – which ironically could be the best chance for him to get appropriate medical care. Both...

How a Well-Intended FDA Policy on Colchicine is Harming Patients

The road to hell is paved with good intentions. The FDA has reaffirmed the truth of this aphorism with its policy about Colchicine. Here's the story: I recently spoke with a friend who has a family member suffering from Familial Mediterranean Fever (FMF), an auto-inflammatory disorder, most commonly seen in eastern Mediterranean populations. The condition is characterized by recurrent painful inflammation of the abdomen, chest and joints, accompanied by fever. FMF is associated with mutation of a gene on chromosome 16 involved with regulating Pyrin, a protein that is part of the inflammatory response. There is no specific test for the disease. Diagnosis is made on the basis of symptoms, family history, and ruling out other conditions. Since the 1960s, Colchicine, a plant extract first used for treatment of gout two thousand years ago, has been used for treating FMF. As an ancient treatment widely used prior to formation of the FDA, Colchicine did not require FDA approval as a new ...